Giorgio G. Galli
Basel, BS 4056, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 22, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.
Journal: Cancer research
Published: November 25, 2025
Author Correction: Targeting the SHOC2-RAS interaction in RAS-mutant cancers.
Journal: Nature
Published: July 02, 2025
Identification and characterization of binders to a cryptic and functional pocket in KRAS.
Journal: Nature communications
Published: October 29, 2024
Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Journal: Nature cancer
Published: June 17, 2024
mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.
Journal: ACS chemical biology
Published: April 24, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer Evolution.
Journal: Cancer discovery
Published: October 04, 2023
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Journal: Nature cancer
Published: May 22, 2023
Protein destabilization underlies pathogenic missense mutations in ARID1B.
Journal: Nature structural & molecular biology
Published: March 10, 2023
Last Updated: 09/26/2026